Qualitative and quantitative assessment of endpoints in clinical trials

被引：0
|
作者：
Fridrik, M. A. [1 ]
机构：
[1] Gen Hosp Linz, Ctr Hematol & Med Oncol, Dept Internal Med 3, Linz, Austria
来源：
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY | 2010年 / 3卷 / 01期
关键词：
Clinical trial; RECIST; endpoints;
D O I：
10.1007/s12254-010-0178-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This review discusses the complexities of different endpoints in clinical trials. A definition of these endpoints and their value for specific situations will be evaluated.
引用
收藏
页码：33 / 36
页数：4
相关论文
共 50 条
  • [21] Surrogates for fracture endpoints in clinical trials
    Khosla, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (06) : 1146 - 1149
  • [22] Use of composite endpoints in clinical trials
    Sankoh, Abdul J.
    Li, Haihong
    D'Agostino, Ralph B., Sr.
    STATISTICS IN MEDICINE, 2016, 35 (02) : 319 - 320
  • [23] Choosing endpoints in clinical studies and trials
    Chauhan, B. C.
    EYE, 2007, 21 (Suppl 1) : S34 - S37
  • [24] Responsiveness of endpoints in osteoporosis clinical trials
    Wells, G
    Cranney, A
    Shea, B
    Tugwell, P
    JOURNAL OF RHEUMATOLOGY, 1997, 24 (06) : 1230 - 1233
  • [25] Justifying the Choice of Endpoints for Clinical Trials
    Begg, Colin B.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (21): : 1594 - 1595
  • [26] Clinical trials design: protocols and endpoints
    MG Wyllie
    International Journal of Impotence Research, 2000, 12 : S53 - S58
  • [27] SURROGATE ENDPOINTS IN CLINICAL-TRIALS
    FRIEDMAN, L
    YUSUF, S
    CONTROLLED CLINICAL TRIALS, 1985, 6 (03): : 222 - 222
  • [28] Assessment Of Worsening In Lupus Clinical Trials: Do The Endpoints Reflect Medical Judgement?
    Thanou, Aikaterini
    Chakravarty, Eliza
    Kamp, Stan
    Carthen, Fredonna C.
    Merrill, Joan T.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1087 - S1088
  • [29] Use of Imaging Endpoints in Clinical Trials
    Gillam, Linda D.
    Leipsic, Jonathon
    Weissman, Neil J.
    JACC-CARDIOVASCULAR IMAGING, 2017, 10 (03) : 296 - 303
  • [30] Endpoints in prostate cancer clinical trials
    Sartor, O
    UROLOGY, 2002, 60 (3A) : 101 - 107
12345